4 Biotech Stocks To Know Walgreens Conducting “Strategic Review” Of U.K-Based Operations Walgreens (NASDAQ: WBA) is currently conducting a “strategic review” of its Boots pharmacy chain in the U.K. Given all this exciting news about Walgreens, I could see investors eyeing WBA stock in the stock market today. He said, “If we see inflation persisting at high levels, longer than expected, if we have to raise interest rates more over time, then we will.” If that wasn’t enough, there is also more inflation-related data on tap today.